Literature DB >> 15756816

Oxygen-binding heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin.

M Zouhair Atassi1, Catherine Childress.   

Abstract

Development of effective resuscitation agents for blood-loss replacement in trauma or surgery is extremely important despite substantial improvements in screening methods of blood from human donors. This paper reports the design and synthesis of peptides that mimic the natural environment of the heme group in myoglobin (Mb) and in the alpha- and beta-subunits of human adult hemoglobin (Hb). The designs were based on the fact that the heme group in the aforementioned proteins is sandwiched between helices E and F. Fifteen test peptides and six control peptides were synthesized, and their ability to form stable complexes with heme was investigated. It was found that none of the control peptides or proteins was able to bind heme. However, each of the peptides that were designed to mimic the E-F helices, and even shorter designs, which removed from this region residues that do not contribute to contacts with the heme group, were each able to bind one mole of heme per mole of peptide forming peptide heme complexes that were stable to manipulation and behaved as single molecular species. Oxygen binding measurements on the reduced peptide-heme complexes showed that these compounds bind oxygen and give visible spectra that were typical of oxygenated heme-proteins. In oxygen binding measurements done under different partial pressures of oxygen, the heme peptide complexes gave hyperbolic oxygen-saturation curves, but showed slight differences in their P50 values. The P50 values ranged from 3.8 mmHg for the heme peptide B7 complex to 13.7 mmHg for the heme peptide D13 complex (under the same conditions, P50 values for Hb and Mb were 34.0 and 5.5 mmHg, respectively). It is concluded that peptide constructs designed to mimic the heme-binding regions of Mb or the Hb subunits were able to form coordinate 1:1 complexes with heme, and these complexes bind oxygen in a manner expected for single subunit heme proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756816     DOI: 10.1007/s10930-004-0604-y

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  40 in total

1.  Affinity labeling of the polyphosphate binding site of hemoglobin.

Authors:  R E Benesch; R Benesch; R D Renthal; N Maeda
Journal:  Biochemistry       Date:  1972-09-12       Impact factor: 3.162

2.  Crystallization and x-ray diffraction data analysis of human deoxyhaemoglobin A(0) fully stripped of any anions.

Authors:  F A Seixas; W F de Azevedo; M F Colombo
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-11

3.  Modification of human hemoglobin with polyethylene glycol : a new candidate for blood substitute.

Authors:  K Ajisaka; Y Iwashita
Journal:  Biochem Biophys Res Commun       Date:  1980-12-16       Impact factor: 3.575

4.  Structure of myoglobin refined at 2-0 A resolution. I. Crystallographic refinement of metmyoglobin from sperm whale.

Authors:  T Takano
Journal:  J Mol Biol       Date:  1977-03-05       Impact factor: 5.469

5.  Structure of human carbonmonoxyhemoglobin at 2.16 A: a snapshot of the allosteric transition.

Authors:  Martin K Safo; James C Burnett; Faik N Musayev; Samuel Nokuri; Donald J Abraham
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-11-23

6.  Localization and synthesis of the hormone-binding regions of the human thyrotropin receptor.

Authors:  M Z Atassi; T Manshouri; S Sakata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

7.  Blood exchange with pyridoxalated and polymerized hemoglobin solution.

Authors:  F DeVenuto; A Zegna
Journal:  Surg Gynecol Obstet       Date:  1982-09

8.  Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics.

Authors:  V D Awasthi; D Garcia; R Klipper; B A Goins; W T Phillips
Journal:  J Pharmacol Exp Ther       Date:  2004-01-12       Impact factor: 4.030

9.  Use of a hemoglobin-based oxygen carrier in the treatment of severe anemia.

Authors:  Aryeh Shander; Raed Alalawi; Petra Seeber; John Lui
Journal:  Obstet Gynecol       Date:  2004-05       Impact factor: 7.661

10.  Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute.

Authors:  W T Phillips; R W Klipper; V D Awasthi; A S Rudolph; R Cliff; V Kwasiborski; B A Goins
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

View more
  2 in total

1.  Immunogenicity of heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin.

Authors:  M Zouhair Atassi; Catherine Childress
Journal:  Protein J       Date:  2005-01       Impact factor: 2.371

2.  Soret spectral and bioinformatic approaches provide evidence for a critical role of the alpha -subunit in assembly of tetrameric hemoglobin.

Authors:  Gayathri Vasudevan; Melisenda J McDonald
Journal:  Protein J       Date:  2006-01       Impact factor: 4.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.